Maynard Um
-
-
-
-
-
-
-
Akari Therapeutics closes $5.5M PIPE, raises $8.3M total in Q2 2026
-
-
-
-
-
-
-
Akari Therapeutics reports preclinical data for pancreatic cancer drug
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Akari Therapeutics (AKTX)
-
-
-
-
-
-
-
Akari Therapeutcis (AKTX) Appoints Abizer Gaslightwala as CEO and President
-
-
-
-
-
-
466,311 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


